HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Boiardi Selected Research

Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)

8/2013Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
8/2008Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
12/2007Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
5/2007Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
4/2006Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
11/2005Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis.
2/2005Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
4/2003Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
4/2002Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Boiardi Research Topics

Disease

23Giant Cell Arteritis (Horton Disease)
08/2022 - 11/2002
12Vasculitis (Vasculitides)
01/2022 - 04/2004
9Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
08/2013 - 04/2002
7Inflammation (Inflammations)
01/2021 - 04/2009
5Takayasu Arteritis (Arteritis, Takayasu's)
11/2022 - 10/2011
4Retroperitoneal Fibrosis
09/2013 - 06/2011
4Psoriatic Arthritis
05/2013 - 08/2003
3Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
04/2018 - 04/2008
3Rheumatoid Arthritis
07/2013 - 06/2006
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2013 - 04/2004
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022 - 10/2011
2Headache (Headaches)
10/2014 - 02/2012
2Psoriasis (Pustulosis Palmaris et Plantaris)
07/2012 - 08/2009
2Synovitis
02/2012 - 12/2009
2Body Weight (Weight, Body)
01/2012 - 05/2007
2Uveitis
09/2010 - 04/2009
1VEXAS syndrome
01/2022
1COVID-19
01/2021
1Churg-Strauss Syndrome (Allergic Angiitis)
04/2018
1Microscopic Polyangiitis
04/2018
1Polyarteritis Nodosa (Periarteritis Nodosa)
04/2018
1Systemic Scleroderma (Systemic Sclerosis)
01/2018
1Fever (Fevers)
05/2016
1Thrombosis (Thrombus)
05/2016
1Arteritis
05/2016
1Cardiovascular Diseases (Cardiovascular Disease)
01/2016
1Inborn Genetic Diseases (Disease, Hereditary)
11/2015
1Pain (Aches)
07/2013
1Lung Diseases (Lung Disease)
07/2013
1Infections
07/2013
1Interstitial Lung Diseases (Interstitial Lung Disease)
07/2013
1Ankylosing Spondylitis
07/2013
1Spine Osteoarthritis
07/2013
1Disease Susceptibility (Diathesis)
05/2013
1Ureteral Obstruction
01/2013
1Behcet Syndrome (Behcet's Syndrome)
12/2012
1Edema (Dropsy)
07/2012
1Weight Loss (Weight Reduction)
02/2012
1Anorexia
02/2012
1Arthritis (Polyarthritis)
10/2011
1Tenosynovitis
12/2009
1Bursitis (Adhesive Capsulitis)
12/2009

Drug/Important Bio-Agent (IBA)

8GlucocorticoidsIBA
01/2021 - 04/2002
6tocilizumab (atlizumab)FDA Link
11/2022 - 10/2011
6Interleukin-6 (Interleukin 6)IBA
03/2019 - 04/2002
6Prednisone (Sone)FDA LinkGeneric
05/2016 - 05/2007
5Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
03/2017 - 08/2008
5Infliximab (Remicade)FDA Link
09/2012 - 04/2003
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 04/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2020 - 10/2003
4Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2014 - 04/2002
4SteroidsIBA
12/2007 - 04/2003
3Rituximab (Mabthera)FDA Link
07/2018 - 07/2013
3CCR5 Receptors (CCR5 Receptor)IBA
09/2013 - 06/2011
3Biological ProductsIBA
07/2013 - 05/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2006 - 08/2003
2Interleukin-22 (IL-22)IBA
08/2022 - 01/2018
2CytokinesIBA
01/2018 - 04/2004
2Interleukin-17 (Interleukin 17)IBA
09/2015 - 05/2013
2Antirheumatic Agents (DMARD)IBA
07/2013 - 08/2003
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2012 - 05/2007
2Etanercept (Enbrel)FDA Link
10/2011 - 12/2007
2Platelet Membrane GlycoproteinsIBA
07/2011 - 10/2007
2Integrin beta3 (GPIIIa)IBA
07/2011 - 10/2007
2OligonucleotidesIBA
09/2010 - 11/2003
2Adrenal Cortex Hormones (Corticosteroids)IBA
02/2005 - 04/2003
1EnzymesIBA
01/2022
1Antimalarials (Antimalarial Agents)IBA
01/2021
1prednylidene (Pred)IBA
01/2021
1AngiostatinsIBA
03/2020
1Angiopoietin-1IBA
03/2020
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2020
1PTX3 proteinIBA
03/2020
1EndostatinsIBA
03/2020
1ParaffinIBA
03/2019
1Formaldehyde (Formol)FDA Link
03/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019
1tuftsin-phosphorylcholineIBA
01/2019
1PlasminogenIBA
01/2017
1Hemoglobins (Hemoglobin)IBA
05/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1SilkFDA Link
11/2015
1Interleukin-9 (Interleukin 9)IBA
09/2015
1Interleukin-8 (Interleukin 8)IBA
09/2015
1Interleukin-4 (Interleukin 4)IBA
09/2015
1Thymic Stromal LymphopoietinIBA
09/2015
1Leflunomide (Arava)FDA LinkGeneric
07/2013
1Aligeron (AS 2)IBA
07/2013
1Pharmaceutical PreparationsIBA
07/2013
1Methotrexate (Mexate)FDA LinkGeneric
07/2013
1InterleukinsIBA
02/2013
1Interleukin-33IBA
02/2013
1Adalimumab (Humira)FDA Link
07/2012
1Proteins (Proteins, Gene)FDA Link
10/2011
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2010
1Codon (Codons)IBA
09/2010

Therapy/Procedure

15Therapeutics
01/2021 - 04/2003
2Biological Therapy
07/2013 - 10/2011
1Contraindications
09/2013
1Conservative Treatment
01/2013